Oppenheimer analyst Jay Olson joins BiotechTV for Analyst Thursdays and talks obesity and earnings

blonca9
Aug 8, 2024
1 min read

Jay Olson shares learnings from a physician survey Oppenheimer conducted on obesity, and comments on Viking, Amgen, Madrigal, Acadia, Bicycle, Incyte, Jasper, and Q32 Bio.

Recent Posts

See All

As federal funding for cancer research has been jeopardized at NIH and academia, Parker Institute for Cancer Immunotherapy is one private institution ready to step up and broaden its impact

Mount Sinai has embraced AI as a drug discovery tool by launching this month its new AI Small Molecule Drug Discovery Center - Professor Avner Schlessinger tells us why

Jones Healthcare & Technology Innovation Conference: Jones Research analysts Soumit Roy and Justin Walsh share their take on biotech and comment on companies they cover

Oppenheimer analyst Jay Olson joins BiotechTV for Analyst Thursdays and talks obesity and earnings

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight